| PACKAGING TYPE: | 10x10 Blister In C-box |
| COMPOSITION: | Thalidomide Capsules Usp 50 Mg |
| FORMULATION: | Capsule |
| Description: | THADOVEX 50 Capsule contains Thalidomide USP 50 mg, an immunomodulatory agent indicated for the treatment of multiple myeloma in combination with other therapies and for the management of moderate to severe erythema nodosum leprosum (ENL). It exerts anti-inflammatory, immunomodulatory, and anti-angiogenic effects, making it an important component of selected oncology and leprosy treatment regimens. Due to its significant safety considerations, including severe fetal risk, THADOVEX 50 Capsule must be prescribed and monitored by qualified healthcare professionals. |
| Side Effects: | Drowsiness Constipation Dizziness Peripheral neuropathy (numbness or tingling in hands and feet) Fatigue |
| How to Use: | Take exactly as prescribed by the physician Swallow the capsule whole with water Preferably take at bedtime to minimize drowsiness, if advised by the physician Do not exceed the prescribed dose |
| Precaution: | Contraindicated during pregnancy due to the risk of severe birth defects Use only under strict specialist medical supervision Effective contraception is essential for patients of childbearing potential as advised by the healthcare provider Regular monitoring for peripheral neuropathy and blood-related parameters may be required Avoid donating blood during treatment and for the recommended period after discontinuation Store in a cool and dry place away from direct sunlight |
| Product Benefits: | Supports treatment of multiple myeloma Helps manage erythema nodosum leprosum (ENL) Provides immunomodulatory and anti-inflammatory effects Inhibits abnormal blood vessel formation associated with certain diseases Used under specialist supervision for |
| Expiry Date: | 2028-05-31 |
Frequently Asked Questions
THADOVEX 50 Capsule is used in the treatment of multiple myeloma and erythema nodosum leprosum (ENL) associated with leprosy. It should only be used under specialist medical supervision.
It contains Thalidomide USP 50 mg.
Thalidomide works by modulating the immune system, reducing inflammation, and inhibiting the growth of abnormal blood vessels that support certain disease processes, particularly in multiple myeloma.










